UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

Journal of internal medicine, 2019-11, Vol.286 (5), p.503-525

2019

Volltextzugriff (PDF)

Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Alimentary pharmacology & therapeutics, 2013-06, Vol.37 (11), p.1084-1092

2013

Volltextzugriff (PDF)

Microbial biofilms in the human gastrointestinal tract

Journal of applied microbiology, 2007-05, Vol.102 (5), p.1187-1196

2007

Volltextzugriff (PDF)

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (6), p.647-662

2012

Volltextzugriff (PDF)

Review article: 2014 UK consensus guidelines – hepatitis C management and direct‐acting anti‐viral therapy

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (12), p.1363-1375

2014

Volltextzugriff (PDF)

Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)

Health technology assessment (Winchester, England), 2009-04, Vol.13 (25), p.iii-iv

2009

Volltextzugriff (PDF)

A proof from the book, perchance

Journal of algebraic combinatorics, 2022-02, Vol.55 (1), p.185-199

Dillon, J. F.

2022

Volltextzugriff (PDF)

The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

Epidemiology and infection, 2012-06, Vol.140 (6), p.1048-1053

2012

Volltextzugriff (PDF)

Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland

Epidemiology and infection, 2013-10, Vol.141 (10), p.2122-2130

2013

Volltextzugriff (PDF)

Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

Journal of hepatology, 2011-11, Vol.55 (5), p.1162-1164

2011

Volltextzugriff (PDF)

Review article: treatment as prevention – targeting people who inject drugs as a pathway towards hepatitis C eradication

Alimentary pharmacology & therapeutics, 2016-07, Vol.44 (2), p.145-156

2016

Volltextzugriff (PDF)

Paracetamol toxicity: epidemiology, prevention and costs to the health‐care system

QJM : An International Journal of Medicine, 2002-09, Vol.95 (9), p.609-619

2002

Volltextzugriff (PDF)

P11 Impact of opiate substitution therapy on hepatitis C treatment oucomes for persons who inject drugs at injecting equipment provision sites in the advance HCV trial

Gut, 2020-09, Vol.69 (Suppl 1), p.A12-A13

2020

Volltextzugriff (PDF)

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

Journal of viral hepatitis, 2015-04, Vol.22 (4), p.399-408

2015

Volltextzugriff (PDF)

Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.299-300

2018

Volltextzugriff (PDF)

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial

The Journal of infection, 2022-12, Vol.85 (6), p.676-682

2022

Volltextzugriff (PDF)

Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991–2006

Epidemiology and infection, 2011-03, Vol.139 (3), p.344-353

2011

Volltextzugriff (PDF)

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

Public health (London), 2024-07, Vol.232, p.153-160

2024

Volltextzugriff (PDF)

Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide

European journal of gastroenterology & hepatology, 2006-04, Vol.18 (4), p.455-456

2006

Volltextzugriff (PDF)

Editorial: sorafenib toxicity, a biomarker of effect?

Alimentary pharmacology & therapeutics, 2017-06, Vol.45 (11), p.1469-1470

2017

Volltextzugriff (PDF)

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

Journal of viral hepatitis, 2016-12, Vol.23 (12), p.1009-1016

2016

Volltextzugriff (PDF)

Microbial Colonization of the Upper Gastrointestinal Tract in Patients with Barrett's Esophagus

Clinical infectious diseases, 2007-07, Vol.45 (1), p.29-38

2007

Volltextzugriff (PDF)

A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland

British journal of cancer, 2008-09, Vol.99 (5), p.805-810

2008

Volltextzugriff (PDF)

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

International journal of epidemiology, 2017-10, Vol.46 (5), p.1391-1391h

2017

Volltextzugriff (PDF)

Limited impact of awareness‐raising campaigns on hepatitis C testing practices among general practitioners

Journal of viral hepatitis, 2017-11, Vol.24 (11), p.944-954

2017

Volltextzugriff (PDF)

1 – 25 von 1.634

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.376)
Mit Volltextzugriff
(1.331)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.086)
Life Sciences & Biomedicine
(758)
Humans
(575)
Female
(325)
Male
(321)
Biological And Medical Sciences
(297)
Physical Sciences
(234)
Medical Sciences
(227)
Middle Aged
(204)
Adult
(203)
Animals
(176)
Technology
(136)
Physics
(128)
Aged
(126)
Gastroenterology & Hepatology
(93)
Adolescent
(81)
Fundamental And Applied Biological Sciences. Psychology
(79)
Social Sciences
(73)
Computer Science
(68)
Infectious Diseases
(66)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade

Oesophageal bacterial biofilm changes in gastro‐oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Microbial biofilms in the human gastrointestinal tract

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

Review article: 2014 UK consensus guidelines – hepatitis C management and direct‐acting anti‐viral therapy

Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE)

A proof from the book, perchance

The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

Prevalence estimates of diagnosed viral hepatitis B, liver condition outcomes and hospitalization costs: a population record-linkage study in Tayside, Scotland

Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

Review article: treatment as prevention – targeting people who inject drugs as a pathway towards hepatitis C eradication

Paracetamol toxicity: epidemiology, prevention and costs to the health‐care system

P11 Impact of opiate substitution therapy on hepatitis C treatment oucomes for persons who inject drugs at injecting equipment provision sites in the advance HCV trial

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

Editorial: there is trouble ahead, but just how much? The troubling reality of America's excesses and NAFLD

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial

Excess morbidity in the hepatitis C-diagnosed population in Scotland, 1991–2006

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide

Editorial: sorafenib toxicity, a biomarker of effect?

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

Microbial Colonization of the Upper Gastrointestinal Tract in Patients with Barrett's Esophagus

A record-linkage study of the development of hepatocellular carcinoma in persons with hepatitis C infection in Scotland

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank

Limited impact of awareness‐raising campaigns on hepatitis C testing practices among general practitioners

Suchergebnisse filtern